Park Ha Biological Technology Co., Ltd. (BYAH) Return on equity 2022–2025
Park Ha Biological Technology Co., Ltd. (BYAH) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-609.9%FY2025 · since FY2022: 127.3% → -609.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -609.9% | -641.7 pp |
| FY2024 | 31.8% | -52.4 pp |
| FY2023 | 84.2% | -43.1 pp |
| FY2022 | 127.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More BYAH financial trends
BYAH RevenueBYAH Net incomeBYAH Net marginBYAH Gross profitBYAH Gross marginBYAH Operating incomeBYAH Operating marginBYAH Operating cash flowBYAH Free cash flowBYAH Capital expendituresBYAH Stock buybacksBYAH Dividends paidBYAH Total assetsBYAH Total liabilitiesBYAH Shareholders’ equityBYAH overview →